Equirab 1500 Injection

The recommended dose is administered by infiltration around the wound site with any remaining volume given intramuscularly away from the vaccine administration site. This product is intended for use in conjunction with a complete rabies vaccination regimen and should not be used as a substitute for active immunization. Equirab 1500 Injection is contraindicated in patients with known hypersensitivity to equine proteins.

Adverse reactions may include local pain, erythema, swelling, and rare systemic hypersensitivity reactions; therefore, appropriate medical supervision is advised during administration. Proper wound cleansing and thorough infiltration of the immunoglobulin are critical for optimal efficacy. Storage conditions require refrigeration at 2-8°C, protected from light. Equirab 1500 Injection is a vital component in rabies post-exposure management, providing immediate passive immunity to reduce the risk of rabies infection following potential exposure.